The effects of salsalate on glycemic control in patients with type 2 diabetes: A randomized trial

Annals of Internal Medicine

Volumn 152, Issue 6, 2010, Pages 346-357

  Goldfine, Allison B ^a   Fonseca, Vivian ^b   Jablonski, Kathleen A ^c   Pyle, Laura ^c   Staten, Myrlene A ^d   Shoelson, Steven E ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; ALBUMIN; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; PLACEBO; SALSALATE; SULFONYLUREA; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; LIPID; PRODRUG; SALICYLIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DIARRHEA; DIET RESTRICTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEARTBURN; HUMAN; HYPOGLYCEMIA; KIDNEY FUNCTION; LOW DRUG DOSE; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGISTRATION; TINNITUS; TREATMENT OUTCOME; UNITED STATES; VOMITING; ADOLESCENT; ALBUMINURIA; BLOOD; CHEMICALLY INDUCED DISORDER; DOUBLE BLIND PROCEDURE; GASTROINTESTINAL DISEASE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; PRODRUGS; SALICYLIC ACIDS; TINNITUS; YOUNG ADULT;

EID: 77950885686     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-6-201003160-00004     Document Type: Article

References (37)

1. Ebstein W. Zur therapie des diabetes mellitus, insbesondere uber die anwendeng der salicylauren natron bei demselben. Berliner Klinische Wochenschrift. 1876;13:337-340
2. Williamson RT. On the treatment of glycosuria and diabetes mellitus with sodium salicylate. BMJ. 1901;1:760-762.
3. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-1801 [PMID: 16823477]
4. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867 [PMID: 17167474]
5. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 2001;293:1673-1677 [PMID: 11533494] (Pubitemid 32807849)
6. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κ B. Nat Med. 2005;11:183-190 [PMID: 15685173]
7. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat Med. 2005;11:191-198 [PMID: 15685170] (Pubitemid 40321355)
8. Kopp E, Ghosh S. Inhibition of NF-κ B by sodium salicylate and aspirin. Science. 1994;265:956-959 [PMID: 8052854]
9. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. Salicylates inhibit I κ B-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol. 1996;156:3961-3969 [PMID: 8621937] (Pubitemid 26137683)
10. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(κ)B kinase-β. Nature. 1998;396:77-80. [PMID: 9817203] (Pubitemid 28520452)
11. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest. 2002;109:1321-1326 [PMID: 12021247] (Pubitemid 34546896)
12. Reid J, Macdougall AI, Andrews MM. Aspirin and diabetes mellitus. Br Med J. 1957;2:1071-1074 [PMID: 13472052]
13. Gilgore SG. The influence of salicylate on hyperglycemia. Diabetes. 1960;9:392-393
14. Chen Y, Zhu J, Lum PY, Yang X, Pinto S, MacNeil DJ, et al. Variations in DNA elucidate molecular networks that cause disease. Nature. 2008;452:429-435 [PMID: 18344982] (Pubitemid 351450844)
15. Loll PJ, Picot D, Garavito RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol. 1995;2:637-643 [PMID: 7552725]
16. Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, Lee J, et al. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci. 2008;1:36-43. [PMID: 19337387]
17. Fleischman A, Shoelson SE, Bernier R, Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care. 2008;31:289-294 [PMID: 17959861] (Pubitemid 351213338)
18. Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2008;3:706-713 [PMID: 18272826]
19. Macisaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, et al. Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia. 2006;49:1686-1689 [PMID: 16752187] (Pubitemid 43848107)
20. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
21. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007;18:2749-2757 [PMID: 17855641] (Pubitemid 47531202)
22. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science. 1996;274:1383-1385 [PMID: 8910280] (Pubitemid 26391464)
23. Frantz B, O'Neill EA. The effect of sodium salicylate and aspirin on NF-kappa B [Letter]. Science. 1995;270:2017-2019 [PMID: 8533099] (Pubitemid 26097196)
24. Jurivich DA, Sistonen L, Kroes RA, Morimoto RI. Effect of sodium salicylate on the human heat shock response. Science. 1992;255:1243-1245 [PMID: 1546322]
25. Fernández-Real JM, López-Bermejo A, Ropero AB, Piquer S, Nadal A, Bassols J, et al. Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab. 2008;93:2523-2530 [PMID: 18460568] (Pubitemid 352008516)
26. Koska J, Ortega E, Bunt JC, Gasser A, Impson J, Hanson RL, et al. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia. 2009;52:385-393 [PMID: 19104769]
27. Wagner JA, Wright EC, Ennis MM, Prince M, Kochan J, Nunez DJ, et al. Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin Pharmacol Ther. 2009;86:619-625 [PMID: 19553931]
28. Morris HG, Sherman NA, McQuain C, Goldlust MB, Chang SF, Harrison LI. Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans. Ther Drug Monit. 1985;7:435-438 [PMID: 3866409] (Pubitemid 16198531)
29. Sweeney JD, Hoernig LA. Hemostatic effects of salsalate in normal subjects and patients with hemophilia A. Thromb Res. 1991;61:23-27 [PMID: 2020937]
30. Edmar D. Effects of salicylates on the gastric mucosa as revealed by roentgen examination and the gastrocamera. Acta Radiol Diagn (Stockh). 1971;11:57-64. [PMID: 4933979]
31. Roth S, Bennett R, Caldron P, Hartman R, Mitchell C, Doucette M, et al. Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study. Semin Arthritis Rheum. 1990;19:11-19 [PMID: 2181673] (Pubitemid 20091342)
32. Lanza F, Rack MF, Doucette M, Ekholm B, Goldlust B, Wilson R. An endoscopic comparison of the gastroduodenal injury seen with salsalate and naproxen. J Rheumatol. 1989;16:1570-1574 [PMID: 2625689] (Pubitemid 20053197)
33. April P, Abeles M, Baraf H, Cohen S, Curran N, Doucette M, et al. Does the acetyl group of aspirin contribute to the antiinflammatory efficacy of salicylic acid in the treatment of rheumatoid arthritis? Semin Arthritis Rheum. 1990;19:20-28 [PMID: 2181674]
34. Souza Lima MA. Ulcers of the small bowel associated with stomach-bypassing salicylates. Arch Intern Med. 1985;145:1139. [PMID: 4004443]
35. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29-34. [PMID: 10873868] (Pubitemid 30432560)
36. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-1821 [PMID: 18946066]
37. Pierce GL, Lesniewski LA, Lawson BR, Beske SD, Seals DR. Nuclear factor-κ B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation. 2009;119:1284-1292 [PMID: 19237660]